Prospects for primary stroke prevention in children with sickle cell anaemia

British Journal of Haematology

Volumn 157, Issue 1, 2012, Pages 14-25

  Jordan, Lori C ^a   Casella, James F ^b   Debaun, Michael R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Child; Primary prevention; Sickle cell anaemia; Stroke; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEMOGLOBIN; HEMOGLOBIN F; HYDROXYUREA; IBUPROFEN; MENINGOCOCCUS VACCINE; PENICILLIN G; PLACEBO; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BLOOD TRANSFUSION; BLOOD VISCOSITY; BOLD SIGNAL; BONE MARROW SUPPRESSION; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN MALARIA; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR DISEASE; CHILD; DEVELOPING COUNTRY; DOPPLER ECHOGRAPHY; EXCHANGE BLOOD TRANSFUSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; IMMUNIZATION; IRON CHELATION; IRON OVERLOAD; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; MOYAMOYA DISEASE; NEUTROPENIA; PATENT FORAMEN OVALE; PATHOPHYSIOLOGY; PATIENT SELECTION; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SICKLE CELL ANEMIA; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BACTERIAL INFECTIONS; BLOOD TRANSFUSION; BRAIN ISCHEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYDROXYUREA; IMMUNIZATION; MALE; STROKE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84858285470     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.09005.x     Document Type: Review

References (102)

1. Adams, R.J. (2005) TCD in sickle cell disease: an important and useful test. Pediatric Radiology, 35, 229-234.
2. Adams, R.J. & Brambilla, D. (2005) Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. New England Journal of Medicine, 353, 2769-2778.
3. Adams, R., McKie, V., Nichols, F., Carl, E., Zhang, D.L., McKie, K., Figueroa, R., Litaker, M., Thompson, W. & Hess, D. (1992a) The use of transcranial ultrasonography to predict stroke in sickle cell disease. New England Journal of Medicine, 326, 605-610.
4. Adams, R.J., Nichols, F.T., Figueroa, R., McKie, V. & Lott, T. (1992b) Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke, 23, 1073-1077.
5. Adams, R.J., McKie, V.C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F.T., Bonds, D.R. & Brambilla, D. (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. New England Journal of Medicine, 339, 5-11.
6. Armstrong, F.D., Thompson, Jr, R.J., Wang, W., Zimmerman, R., Pegelow, C.H., Miller, S., Moser, F., Bello, J., Hurtig, A. & Vass, K. (1996) Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychology Committee of the Cooperative Study of sickle cell disease. Pediatrics, 97, 864-870.
7. Armstrong-Wells, J., Grimes, B., Sidney, S., Kronish, D., Shiboski, S.C., Adams, R.J. & Fullerton, H.J. (2009) Utilization of TCD screening for primary stroke prevention in children with sickle cell disease. Neurology, 72, 1316-1321.
8. Bernaudin, F., Verlhac, S., Freard, F., Roudot-Thoraval, F., Benkerrou, M., Thuret, I., Mardini, R., Vannier, J.P., Ploix, E., Romero, M., Casse-Perrot, C., Helly, M., Gillard, E., Sebag, G., Kchouk, H., Pracros, J.P., Finck, B., Dacher, J.N., Ickowicz, V., Raybaud, C., Poncet, M., Lesprit, E., Reinert, P.H. & Brugieres, P. (2000) Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. Journal of Child Neurology, 15, 333-343.
9. Bernaudin, F., Verlhac, S., Coic, L., Lesprit, E., Brugieres, P. & Reinert, P. (2005) Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler. Pediatric Radiology, 35, 242-248.
10. Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Chevret, S., Hau, I., Coic, L., Leveille, E., Lemarchand, E., Lesprit, E., Abadie, I., Medejel, N., Madhi, F., Lemerle, S., Biscardi, S., Bardakdjian, J., Galacteros, F., Torres, M., Kuentz, M., Ferry, C., Socie, G., Reinert, P. & Delacourt, C. (2011) Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood, 117, 1130-1140.
11. van Besien, K., Koshy, M., Anderson-Shaw, L., Talishy, N., Dorn, L., Devine, S., Yassine, M. & Kodish, E. (2001) Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions. Bone Marrow Transplantation, 28, 545-549.
12. Bjornson, A.B., Falletta, J.M., Verter, J.I., Buchanan, G.R., Miller, S.T., Pegelow, C.H., Iyer, R.V., Johnstone, H.S., DeBaun, M.R., Wethers, D.L., Wang, W.C., Woods, G.M., Holbrook, C.T., Becton, D.L., Kinney, T.R., Reaman, G.H., Kalinyak, K., Grossman, N.J., Vichinsky, E. & Reid, C.D. (1996) Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. Journal of Pediatrics, 129, 828-835.
13. Brass, L.M., Prohovnik, I., Pavlakis, S.G., DeVivo, D.C., Piomelli, S. & Mohr, J.P. (1991) Middle cerebral artery blood velocity and cerebral blood flow in sickle cell disease. Stroke, 22, 27-30.
14. Brittenham, G.M. (2011) Iron-chelating therapy for transfusional iron overload. New England Journal of Medicine, 364, 146-156.
15. Bulas, D. (2005) Screening children for sickle cell vasculopathy: guidelines for transcranial Doppler evaluation. Pediatric Radiology, 35, 235-241.
16. Bulas, D.I., Jones, A., Seibert, J.J., Driscoll, C., O'Donnell, R. & Adams, R.J. (2000) Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation. Pediatric Radiology, 30, 733-738.
17. Casella, J.F., King, A.A., Barton, B., White, D.A., Noetzel, M.J., Ichord, R.N., Terrill, C., Hirtz, D., McKinstry, R.C., Strouse, J.J., Howard, T.H., Coates, T.D., Minniti, C.P., Campbell, A.D., Vendt, B.A., Lehmann, H. & Debaun, M.R. (2010) Design of the silent cerebral infarct transfusion (SIT) trial. Pediatric Hematology Oncology, 27, 69-89.
18. Chang, C.J., Chang, W.N., Huang, L.T., Chang, Y.C., Huang, S.C., Hung, P.L., Ho, H.H., Chang, C.S., Wang, K.W., Cheng, B.C., Lui, C.C., Chang, H.W. & Lu, C.H. (2003) Cerebral infarction in perinatal and childhood bacterial meningitis. Quarterly Journal of Medicine, 96, 755-762.
19. Charache, S., Terrin, M.L., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V., McMahon, R.P. & Bonds, D.R. (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in sickle cell anemia. New England Journal of Medicine, 332, 1317-1322.
20. Chintu, C., Gupta, K., Osborne, C. & Masona, J.M. (1983) Clinical trial of the protective role of polyvalent pneumococcal vaccine in sickle cell anaemia patients in Zambia. Medical Journal of Zambia, 17, 73-76.
21. Cokic, V.P., Smith, R.D., Beleslin-Cokic, B.B., Njoroge, J.M., Miller, J.L., Gladwin, M.T. & Schechter, A.N. (2003) Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. Journal of Clinical Investigation, 111, 231-239.
22. Deane, C.R., Goss, D., Bartram, J., Pohl, K.R., Height, S.E., Sibtain, N., Jarosz, J., Thein, S.L. & Rees, D.C. (2010) Extracranial internal carotid arterial disease in children with sickle cell anemia. Journal of Hematology, 95, 1287-1292.
23. DeBaun, M.R., Derdeyn, C.P. & McKinstry, III, R.C. (2006) Etiology of strokes in children with sickle cell anemia. Mental Retardation and Developmental Disabilities Research Reviews, 12, 192-199.
24. DeBaun, M.R., Sarnaik, S.A., Rodeghier, M.J., Minniti, C.P., Howard, T.H., Iyer, R.V., Inusa, B., Telfer, P.T., Kirby-Allen, M., Quinn, C.T., Bernaudin, F., Airewele, G., Woods, G.M., Panepinto, J.A., Fuh, B., Kwiatkowski, J.K., King, A.A., Rhodes, M.M., Thompson, A.A., Heiny, M.E., Redding-Lallinger, R.C., Kirkham, F.J., Sabio, H., Gonzalez, C.E., Saccente, S.L., Kalinyak, K.A., Strouse, J.J., Fixler, J.M., Gordon, M.O., Miller, J.P., Ichord, R.N. & Casella, J.F. (2011) Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, gender and relative high systolic blood pressure. Blood, doi:.
25. Dobson, S.R., Holden, K.R., Nietert, P.J., Cure, J.K., Laver, J.H., Disco, D. & Abboud, M.R. (2002) Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood, 99, 3144-3150.
26. Dowling, M.M. & Ikemba, C.M. (2011) Intracardiac shunting and stroke in children: a systematic review. Journal of Child Neurology, 26, 72-82.
27. Dowling, M.M., Quinn, C.T., Rogers, Z.R. & Buchanan, G.R. (2010a) Acute silent cerebral infarction in children with sickle cell anemia. Pediatric Blood and Cancer, 54, 461-464.
28. Dowling, M.M., Lee, N., Quinn, C.T., Rogers, Z.R., Boger, D., Ahmad, N., Ramaciotti, C. & Buchanan, G.R. (2010b) Prevalence of intracardiac shunting in children with sickle cell disease and stroke. Journal of Pediatrics, 156, 645-650.
29. Earley, C.J., Kittner, S.J., Feeser, B.R., Gardner, J., Epstein, A., Wozniak, M.A., Wityk, R., Stern, B.J., Price, T.R., Macko, R.F., Johnson, C., Sloan, M.A. & Buchholz, D. (1998) Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology, 51, 169-176.
30. Enninful-Eghan, H., Moore, R.H., Ichord, R., Smith-Whitley, K. & Kwiatkowski, J.L. (2010) Transcranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease. Journal of Pediatrics, 157, 479-484.
31. Fullerton, H.J., Wu, Y.W., Zhao, S. & Johnston, S.C. (2003) Risk of stroke in children: ethnic and gender disparities. Neurology, 61, 189-194.
32. Fullerton, H.J., Wu, Y.W., Sidney, S. & Johnston, S.C. (2007) Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics, 119, 495-501.
33. Fullerton, H.J., Elkind, M.S., Barkovich, A.J., Glaser, C., Glidden, D., Hills, N.K., Leiva-Salinas, C., Wintermark, M. & Deveber, G.A. (2011) The Vascular Effects of Infection in Pediatric Stroke (VIPS) study. Journal of Child Neurology, 26, 1101-1110.
34. Gebreyohanns, M. & Adams, R.J. (2004) Sickle cell disease: primary stroke prevention. CNS Spectrums, 9, 445-449.
35. Giroud, M., Lemesle, M., Gouyon, J.B., Nivelon, J.L., Milan, C. & Dumas, R. (1995) Cerebrovascular disease in children under 16years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. Journal of Clinical Epidemiology, 48, 1343-1348.
36. Gorman, M.J., Nystrom, K., Carbonella, J. & Pearson, H. (2009) Submandibular TCD approach detects post-bulb ICA stenosis in children with sickle cell anemia. Neurology, 73, 362-365.
37. Hankinson, T.C., Bohman, L.E., Heyer, G., Licursi, M., Ghatan, S., Feldstein, N.A. & Anderson, R.C. (2008) Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis. Journal of Neurosurgery. Pediatrics, 1, 211-216.
38. Herold, S., Brozovic, M., Gibbs, J., Lammertsma, A.A., Leenders, K.L., Carr, D., Fleming, J.S. & Jones, T. (1986) Measurement of regional cerebral blood flow, blood volume and oxygen metabolism in patients with sickle cell disease using positron emission tomography. Stroke, 17, 692-698.
39. Hills, N.K., Johnston, S.C., Sidney, S. & Fullerton, H.J. (2009) Minor infection predisposes to arterial ischemic stroke in children. Stroke, 40, e124.
40. Hord, J., Byrd, R., Stowe, L., Windsor, B. & Smith-Whitley, K. (2002) Streptococcus pneumoniae sepsis and meningitis during the penicillin prophylaxis era in children with sickle cell disease. Journal of Pediatric Hematology and Oncology, 24, 470-472.
41. Hsieh, M.M., Fitzhugh, C.D. & Tisdale, J.F. (2011) Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now. Blood, 118, 1197-1207.
42. Hulbert, M.L., Scothorn, D.J., Panepinto, J.A., Scott, J.P., Buchanan, G.R., Sarnaik, S., Fallon, R., Chu, J.Y., Wang, W., Casella, J.F., Resar, L., Berman, B., Adamkiewicz, T., Hsu, L.L., Smith-Whitley, K., Mahoney, D., Woods, G., Watanabe, M. & DeBaun, M.R. (2006) Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia. Journal of Pediatrics, 149, 710-712.
43. Hulbert, M.L., McKinstry, R.C., Lacey, J.L., Moran, C.J., Panepinto, J.A., Thompson, A.A., Sarnaik, S.A., Woods, G.M., Casella, J.F., Inusa, B., Howard, J., Kirkham, F.J., Anie, K.A., Mullin, J.E., Ichord, R., Noetzel, M., Yan, Y., Rodeghier, M. & Debaun, M.R. (2011) Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood, 117, 772-779.
44. Idro, R., Jenkins, N.E. & Newton, C.R. (2005) Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurology, 4, 827-840.
45. Inwald, D.P., Kirkham, F.J., Peters, M.J., Lane, R., Wade, A., Evans, J.P. & Klein, N.J. (2000) Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia. British Journal of Haematology, 111, 474-481.
46. Jones, A., Granger, S., Brambilla, D., Gallagher, D., Vichinsky, E., Woods, G., Berman, B., Roach, S., Nichols, F. & Adams, R.J. (2005) Can peak systolic velocities be used for prediction of stroke in sickle cell anemia?Pediatric Radiology, 35, 66-72.
47. Kandeel, A.Y., Zimmerman, R.A. & Ohene-Frempong, K. (1996) Comparison of magnetic resonance angiography and conventional angiography in sickle cell disease: clinical significance and reliability. Neuroradiology, 38, 409-416.
48. Kodish, E., Lantos, J., Stocking, C., Singer, P.A., Siegler, M. & Johnson, F.L. (1991) Bone marrow transplantation for sickle cell disease. A study of parents' decisions. New England Journal of Medicine, 325, 1349-1353.
49. Korogi, Y., Takahashi, M., Nakagawa, T., Mabuchi, N., Watabe, T., Shiokawa, Y., Shiga, H., O'Uchi, T., Miki, H., Horikawa, Y., Fujiwara, S. & Furuse, M. (1997) Intracranial vascular stenosis and occlusion: MR angiographic findings. American Journal of Neuroradiology, 18, 135-143.
50. Kuwabara, Y., Ichiya, Y., Otsuka, M., Tahara, T., Gunasekera, R., Hasuo, K., Masuda, K., Matsushima, T. & Fukui, M. (1990) Cerebral hemodynamic change in the child and the adult with moyamoya disease. Stroke, 21, 272-277.
51. Kwiatkowski, J.L., Granger, S., Brambilla, D.J., Brown, R.C., Miller, S.T. & Adams, R.J. (2006) Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial. British Journal of Haematology, 134, 333-339.
52. Kwiatkowski, J.L., Zimmerman, R.A., Pollock, A.N., Seto, W., Smith-Whitley, K., Shults, J., Blackwood-Chirchir, A. & Ohene-Frempong, K. (2009) Silent infarcts in young children with sickle cell disease. British Journal of Haematology, 146, 300-305.
53. Lindsey, T., Watts-Tate, N., Southwood, E., Routhieaux, J., Beatty, J., Diane, C., Phillips, M., Lea, G., Brown, E. & DeBaun, M.R. (2005) Chronic blood transfusion therapy practices to treat strokes in children with sickle cell disease. Journal of American Academy of Nurse Practitioners, 17, 277-282.
54. Lucania, G., Vitrano, A., Filosa, A. & Maggio, A. (2011) Chelation treatment in sickle-cell-anaemia: much ado about nothing?British Journal of Haematology, 154, 545-555.
55. MacDonald, T.M. & Wei, L. (2006) Is there an interaction between the cardiovascular protective effects of low-dose aspirin and ibuprofen?Basic and Clinical Pharmacology and Toxicology, 98, 275-280.
56. McCarville, M.B., Goodin, G.S., Fortner, G., Li, C.S., Smeltzer, M.P., Adams, R. & Wang, W. (2008) Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia. Pediatric Blood & Cancer, 50, 818-821.
57. McGann, P.T., Howard, T.A., Flanagan, J.M., Lahti, J.M. & Ware, R.E. (2011) Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposure. British Journal of Haematology, 154, 134-140.
58. Merkel, K.H., Ginsberg, P.L., Parker, Jr, J.C. & Post, M.J. (1978) Cerebrovascular disease in sickle cell anemia: a clinical, pathological and radiological correlation. Stroke, 9, 45-52.
59. de Montalembert, M., Beauvais, P., Bachir, D., Galacteros, F. & Girot, R. (1993) Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence. French Study Group on sickle cell disease. European Journal of Pediatrics, 152, 201-204.
60. National Institutes of Health, National Heart, Lung, and Blood Institute (2002) The management of sickle cell disease. NIH Publication No. 02-2117.
61. Neish, A.S., Blews, D.E., Simms, C.A., Merritt, R.K. & Spinks, A.J. (2002) Screening for stroke in sickle cell anemia: comparison of transcranial Doppler imaging and nonimaging US techniques. Radiology, 222, 709-714.
62. Nichols, F.T., Jones, A.M. & Adams, R.J. (2001) Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing. Journal of Neuroimaging, 11, 354-362.
63. Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., Wethers, D.L., Pegelow, C.H. & Gill, F.M. (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood, 91, 288-294.
64. Osamo, N.O., Photiades, D.P. & Famodu, A.A. (1981) Therapeutic effect of aspirin in sickle cell anaemia. Acta Haematologica, 66, 102-107.
65. Pavlakis, S.G., Rees, R.C., Huang, X., Brown, R.C., Casella, J.F., Iyer, R.V., Kalpatthi, R., Luden, J., Miller, S.T., Rogers, Z.R., Thornburg, C.D., Wang, W.C. & Adams, R.J. (2010) Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial. Pediatric Blood & Cancer, 54, 256-259.
66. Pegelow, C.H., Colangelo, L., Steinberg, M., Wright, E.C., Smith, J., Phillips, G. & Vichinsky, E. (1997) Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. American Journal of Medicine, 102, 171-177.
67. Pegelow, C.H., Macklin, E.A., Moser, F.G., Wang, W.C., Bello, J.A., Miller, S.T., Vichinsky, E.P., DeBaun, M.R., Guarini, L., Zimmerman, R.A., Younkin, D.P., Gallagher, D.M. & Kinney, T.R. (2002) Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood, 99, 3014-3018.
68. van der Plas, E.M., van den Tweel, X.W., Geskus, R.B., Heijboer, H., Biemond, B.J., Peters, M. & Fijnvandraat, K. (2011) Mortality and causes of death in children with sickle cell disease in the Netherlands, before the introduction of neonatal screening. British Journal of Haematology, 155, 106-110.
69. Prohovnik, I., Pavlakis, S.G., Piomelli, S., Bello, J., Mohr, J.P., Hilal, S. & De Vivo, D.C. (1989) Cerebral hyperemia, stroke, and transfusion in sickle cell disease. Neurology, 39, 344-348.
70. Prohovnik, I., Hurlet-Jensen, A., Adams, R., De Vivo, D. & Pavlakis, S.G. (2009) Hemodynamic etiology of elevated flow velocity and stroke in sickle-cell disease. Journal of Cerebral Blood Flow and Metabolism, 29, 803-810.
71. Quinn, C.T., Variste, J. & Dowling, M.M. (2009) Haemoglobin oxygen saturation is a determinant of cerebral artery blood flow velocity in children with sickle cell anaemia. British Journal of Haematology, 145, 500-505.
72. Qureshi, A.I., Feldmann, E., Gomez, C.R., Johnston, S.C., Kasner, S.E., Quick, D.C., Rasmussen, P.A., Suri, M.F., Taylor, R.A. & Zaidat, O.O. (2009) Intracranial atherosclerotic disease: an update. Annals of Neurology, 66, 730-738.
73. Reinert, P., Benkerrou, M., de Montalembert, M., Lesprit, E., Abadie, I., Bernaudin, F., Doit, C., Bingen, E., Tetelboum, R. & Bonnet, E. (2007) Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease. Pediatric Infectious Disease Journal, 26, 1105-1109.
74. Riddington, C. & Owusu-Ofori, S. (2002) Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database of Systematic Reviews, 3, CD003427.
75. Roach, E.S., Golomb, M.R., Adams, R., Biller, J., Daniels, S., Deveber, G., Ferriero, D., Jones, B.V., Kirkham, F.J., Scott, R.M. & Smith, E.R. (2008) Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke; A Journal of Cerebral Circulation, 39, 2644-2691.
76. Rodgers, G.P., Walker, E.C. & Podgor, M.J. (1993) Is "relative" hypertension a risk factor for vaso-occlusive complications in sickle cell disease?American Journal of the Medical Science, 305, 150-156.
77. Rothman, S.M., Fulling, K.H. & Nelson, J.S. (1986) Sickle cell anemia and central nervous system infarction: a neuropathological study. Annals of Neurology, 20, 684-690.
78. Sarode, R., Matevosyan, K., Rogers, Z.R., Burner, J.D. & Rutherford, C. (2011) Advantages of isovolemic hemodilution-red cell exchange therapy to prevent recurrent stroke in sickle cell anemia patients. Journal of Clinical Apheresis, 26, 200-207.
79. Schatz, J., Brown, R.T., Pascual, J.M., Hsu, L. & DeBaun, M.R. (2001) Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease. Neurology, 56, 1109-1111.
80. Schror, K. (2007) Aspirin and Reye syndrome: a review of the evidence. Paediatric Drugs, 9, 195-204.
81. Sebire, G., Meyer, L. & Chabrier, S. (1999) Varicella as a risk factor for cerebral infarction in childhood: a case-control study. Annals of Neurology, 45, 679-680.
82. Seibert, J.J., Miller, S.F., Kirby, R.S., Becton, D.L., James, C.A., Glasier, C.M., Wilson, A.R., Kinder, D.L. & Berry, D.H. (1993) Cerebrovascular disease in symptomatic and asymptomatic patients with sickle cell anemia: screening with duplex transcranial Doppler US - correlation with MR imaging and MR angiography. Radiology, 189, 457-466.
83. Seibert, J.J., Glasier, C.M., Kirby, R.S., Allison, J.W., James, C.A., Becton, D.L., Kinder, D.L., Cox, K.S., Flick, E.L., Lairry, F., Jackson, J.F. & Graves, R.A. (1998) Transcranial Doppler, MRA, and MRI as a screening examination for cerebrovascular disease in patients with sickle cell anemia: an 8-year study. Pediatric Radiology, 28, 138-142.
84. Serjeant, G.R. (1985) Treatment of sickle cell disease in early childhood in Jamaica. American Journal of Pediatrics Hematology and Oncology, 7, 235-239.
85. Smith, E.R., McClain, C.D., Heeney, M. & Scott, R.M. (2009) Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Neurosurgical Focus, 26, E10.
86. Steinberg, M.H., Barton, F., Castro, O., Pegelow, C.H., Ballas, S.K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., Varma, M., Ramirez, G., Adler, B., Smith, W., Carlos, T., Ataga, K., DeCastro, L., Bigelow, C., Saunthararajah, Y., Telfer, M., Vichinsky, E., Claster, S., Shurin, S., Bridges, K., Waclawiw, M., Bonds, D. & Terrin, M. (2003) Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9years of treatment. Journal of the American Medical Association, 289, 1645-1651.
87. Steinberg, M.H., McCarthy, W.F., Castro, O., Ballas, S.K., Armstrong, F.D., Smith, W., Ataga, K., Swerdlow, P., Kutlar, A., DeCastro, L. & Waclawiw, M.A. (2010) The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5year follow-up. American Journal of Hematology, 85, 403-408.
88. Strandgaard, S. & Paulson, O.B. (1984) Cerebral autoregulation. Stroke, 15, 413-416.
89. Strouse, J.J., Cox, C.S., Melhem, E.R., Lu, H., Kraut, M.A., Razumovsky, A., Yohay, K., van Zijl, P.C. & Casella, J.F. (2006a) Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemia (SCA). Blood, 108, 379-381.
90. Strouse, J.J., Hulbert, M.L., DeBaun, M.R., Jordan, L.C. & Casella, J.F. (2006b) Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. Pediatrics, 118, 1916-1924.
91. Strouse, J.J., Lanzkron, S., Beach, M.C., Haywood, C., Park, H., Witkop, C., Wilson, R.F., Bass, E.B. & Segal, J.B. (2008) Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics, 122, 1332-1342.
92. Telfer, P.T., Evanson, J., Butler, P., Hemmaway, C., Abdulla, C., Gadong, N., Whitmarsh, S., Kaya, B. & Kirkham, F.J. (2011) Cervical carotid artery disease in sickle cell disease: clinical and radiological features. Blood, 118, 6192-6199.
93. Thigpen, M.C., Whitney, C.G., Messonnier, N.E., Zell, E.R., Lynfield, R., Hadler, J.L., Harrison, L.H., Farley, M.M., Reingold, A., Bennett, N.M., Craig, A.S., Schaffner, W., Thomas, A., Lewis, M.M., Scallan, E. & Schuchat, A. (2011) Bacterial meningitis in the United States, 1998-2007. New England Journal of Medicine, 364, 2016-2025.
94. Vernacchio, L., Neufeld, E.J., MacDonald, K., Kurth, S., Murakami, S., Hohne, C., King, M. & Molrine, D. (1998) Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. Journal of Pediatrics, 133, 275-278.
95. Vichinsky, E.P., Neumayr, L.D., Earles, A.N., Williams, R., Lennette, E.T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., Daeschner, C. & Manci, E.A. (2000) Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal of Medicine, 342, 1855-1865.
96. Walters, M.C., Patience, M., Leisenring, W., Eckman, J.R., Scott, J.P., Mentzer, W.C., Davies, S.C., Ohene-Frempong, K., Bernaudin, F., Matthews, D.C., Storb, R. & Sullivan, K.M. (1996) Bone marrow transplantation for sickle cell disease. New England Journal of Medicine, 335, 369-376.
97. Walters, M.C., Hardy, K., Edwards, S., Adamkiewicz, T., Barkovich, J., Bernaudin, F., Buchanan, G.R., Bunin, N., Dickerhoff, R., Giller, R., Haut, P.R., Horan, J., Hsu, L.L., Kamani, N., Levine, J.E., Margolis, D., Ohene-Frempong, K., Patience, M., Redding-Lallinger, R., Roberts, I.A., Rogers, Z.R., Sanders, J.E., Scott, J.P. & Sullivan, K.M. (2010) Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Biology of Blood Marrow Transplant, 16, 263-272.
98. Wang, W.C. (2007) The pathophysiology, prevention, and treatment of stroke in sickle cell disease. Current Opinion Hematology, 14, 191-197.
99. Wang, W.C., Ware, R.E., Miller, S.T., Iyer, R.V., Casella, J.F., Minniti, C.P., Rana, S., Thornburg, C.D., Rogers, Z.R., Kalpatthi, R.V., Barredo, J.C., Brown, R.C., Sarnaik, S.A., Howard, T.H., Wynn, L.W., Kutlar, A., Armstrong, F.D., Files, B.A., Goldsmith, J.C., Waclawiw, M.A., Huang, X. & Thompson, B.W. (2011) Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet, 377, 1663-1672.
100. Wierenga, K.J., Serjeant, B.E. & Serjeant, G.R. (2001) Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease. Journal of Pediatrics, 139, 438-442.
101. Zimmerman, S.A., Schultz, W.H., Davis, J.S., Pickens, C.V., Mortier, N.A., Howard, T.A. & Ware, R.E. (2004) Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood, 103, 2039-2045.
102. Zou, P., Helton, K.J., Smeltzer, M., Li, C.S., Conklin, H.M., Gajjar, A., Wang, W.C., Ware, R.E. & Ogg, R.J. (2011) Hemodynamic responses to visual stimulation in children with sickle cell anemia. Brain Imaging Behavior, 5, 295-306.